Newsroom

News

With funding from the Lower Saxony Ministry of Science and Culture (MWK) and the Volkswagen Foundation, the Helmholtz Centre for Infection Research (HZI) in Braunschweig has launched the large-scale project HUMAN. Interdisciplinary teams are investigating the interactions between humans, bacteria and viruses. Six internationally recruited young researchers are currently setting up new research groups with innovative approaches and bringing cutting-edge research from Stanford, Stockholm and Vienna, among others, to Lower Saxony. The project, led by Prof. Josef Penninger, Scientific Director of the HZI, initially has around 32 million euros available in the program “zukunft.niedersachsen”, with the option of an increase to up to 70 million euros after a successful interim evaluation. Today, the established groups were presented to Lower Saxony's Minister of Science, Falko Mohrs, and the CEO of the Volkswagen Foundation, Dr. Georg Schütte.

02.02.2026

HZI Campus

Illustration of cells with transparent membranes and structures inside the cells

News

How Long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Centre for Individualised Infection Medicine (CiiM). Using their approach of examining different molecular levels within individual cells, the researchers identified a specific condition in immune cells that was directly associated with elevated inflammation markers, fatigue, and respiratory problems in patients with Long COVID. The study was published in the journal Nature Immunology. The CiiM is a joint institution of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH).

29.01.2026

CiiM

Futuristic stock photo: Doctor pressing AI button

News

The Helmholtz Association is kicking off 2026 with new research initiatives on strategic future topics to bring technological breakthroughs into practical application more quickly. The Helmholtz initiatives “Biomedical Engineering Initiative,” “Water Safety and Security Initiative,” and “Quantum Use Challenge” are generating innovative solutions – from needle-free blood glucose measurement via wearables to quantum sensors for more powerful batteries and innovative concepts for water management in large cities. The initiatives are being developed in close cooperation with partners from politics, business, and society and address key technologies and strategic research areas of the German government’s High-Tech Agenda. Four projects of the Helmholtz Centre for Infection Research (HZI) and its sites in Greifswald, Saarbrücken and Würzburg are part of the new research campaigns.

22.01.2026

HZI Campus

HIPS

HIRI

HIOH

Person wearing purple gloves performing chemical synthesis

News

For decades, tuberculosis (TB) has been one of the deadliest infectious diseases worldwide. Resistant strains of Mycobacterium tuberculosis are particularly problematic, as many established drugs are becoming increasingly ineffective against them. However, a research team from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Saarland University has now discovered a new family of natural substances that exhibit excellent activity against the TB pathogen. They have also investigated these substances so comprehensively that targeted further development is possible for the first time. The researchers have now published their findings in the journal Angewandte Chemie International Edition.

21.01.2026

HIPS

News

Two collaborative projects involving the Helmholtz Centre for Infection Research (HZI) are being funded with 100,000 euros each from the joint program "zukunft.niedersachsen" of the state of Lower Saxony and the Volkswagen Foundation. Both projects result from the collaboration between HZI and the MRC–University of Glasgow Centre for Virus Research (CVR), established in 2024 as part of a cooperation between the Helmholtz Association and the British Medical Research Council (MRC). The funded MARITH project will grow organoids from throat tonsil tissue to study the development of immunological memory in humans, while the ViReST project analyzes the sites of viral replication in respiratory infections and their impact on virus transmission.

20.01.2026

HZI Campus

News

The global skin care company Beiersdorf and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have entered into a long-term, exclusive partnership. In this collaboration they aim to investigate the role of the skin microbiome in maintaining healthy skin. The goal is to identify natural products produced by microorganisms on the skin that have a positive effect on skin balance. The project is based on extensive data sets on microorganisms that inhabit human skin.

13.01.2026

HIPS

Back to the first page
...
12
13
14
15
...
163

HZI in the media

die Bundibugyo-Virusvariante entsteht. Forschende des Helmholtz-Zentrums für Infektionsforschung hatten unlängst Hinweise gefunden , dass

07.10.2026

Medscape

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

07.10.2026

ZDFheute

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

07.10.2026

Der Tagesspiegel

in predictable ways. A new study from the Helmholtz Centre for Infection Research (HZI) in Braunschweig now shows that this picture is far

07.10.2026

Scienmag Science Magazine

... nicht isoliert wirken. Wie Forschende des Helmholtz-Zentrums für Infektionsforschung (HZI) gemeinsam mit Teams der Universität ...

06.10.2026

Ad Hoc News

Recent research conducted by the Helmholtz Center for Infection Research (HZI) in collaboration with the European Molecular Biology

06.10.2026

Life Technology™

Technische Universität Braunschweig, das HZI – Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die Medizinische Hochschule ...

04.10.2026

schleswig-holstein.de

the Institute of Science and Technology Austria and the Helmholtz Centre for Infection Research in Braunschweig, Germany. Their combined

04.10.2026

Scienmag Science Magazine

... die klinische Validität. Ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) hat mit „Metax“ nun einen ...

02.10.2026

Analytik.de

Mikrobiologen auch Kolleg*innen vom IST Austria und dem HZI in Braunschweig gehören: Inhibitoren von Aktin unterbinden diese dynamischen

01.10.2026

Science.apa.at

... der Medizinischen Hochschule Hannover sowie am Helmholtz-Zentrum für Infektionsforschung tätig ist. Als Co-Autor ist zudem ...

30.09.2026

Ad Hoc News

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

30.09.2026

Phys.org

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.